Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ketamine in OCD: Efficacy and Effects on Stress and Cognition
Sponsor: Medical University of Vienna
Summary
The main goal of this trial is to demonstrate therapeutic efficacy of low dose ketamine in patients with OCD. We expect that ketamine will alleviate symptoms in the hours following application, but also - if effective - that the anti-OCD effects might last for several days after a single infusion.
Official title: Ketamine Therapy in Obsessive-compulsive Disorder and Its Effects on Neuropsychological Function Under Stress in a Cross-over Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2022-10-01
Completion Date
2026-06
Last Updated
2025-06-25
Healthy Volunteers
No
Interventions
Ketamine 50 MG/ML Blinded
See also Arm description
Midazolam
See also Arm description
Ketamine 50 MG/ML Open Label
Open Label Follow Up (up to 8 Infusions)
Treatment as Usual (TAU)
Treatment as Usual may include psychotherapy, pharmacotherapy, physiotherapy, ergotherapy, or a combination of these-at the discretion of the treating physician, independently of the study.
Locations (1)
Medical University of Vienna, Department of Psychiatry and Psychotherapy
Vienna, Vienna, Austria